Shenzhen NeuroPlus has reportedly raised “tens of millions” of renminbi in a seed financing round solely led by Brain Venture Capital. The proceeds will be directed towards medical device research and development, pre-clinical studies, and clinical trial filings. The Guangming Brain Science Technology Industry Innovation Center will provide NeuroPlus with incubation and empowerment services.
Company Overview and Innovation
Founded in 2018, NeuroPlus is focused on the field of non-invasive neuromodulation and bioelectronic medicine. The company is at the forefront of innovation, exploring the application of emerging technologies such as non-invasive neuromodulation, brain-computer interfaces, smart wearable devices, and mobile medical solutions. NeuroPlus has launched the industry-leading “BCI (Brain-Computer Interface)-tES (Transcranial Electrical Stimulation) Closed-Loop Solution” and a portable transcranial electrical stimulation trainer.
Future Outlook and Collaboration
Moving forward, NeuroPlus plans to leverage Internet medicine, big data, and digital health initiatives. The company aims to collaborate with global companies, clinics, and academic institutions to advance its mission of developing innovative medical solutions. This seed financing marks a significant step in NeuroPlus’s journey to transform the field of non-invasive neuromodulation and bioelectronic medicine.-Fineline Info & Tech
